tradingkey.logo

Briacell Therapeutics Corp <BCT.TO> expected to post a loss of $1.76 a share - Earnings Preview

ReutersJun 13, 2025 8:08 PM
  • Briacell Therapeutics Corp BCT.TO is expected to show no change in quarterly revenue when it reports results on June 16 (estimated) for the period ending April 30 2025

  • ​LSEG's mean analyst estimate for Briacell Therapeutics Corp is for a loss of $1.76 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Briacell Therapeutics Corp is $128.50​, above​ its last closing price of $3.53. ​​​

This summary was machine generated June 13 at 20:08 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI